VSTM
NASDAQ · Biotechnology
Verastem Inc
$6.19
+0.28 (+4.74%)
Open$6.58
Previous Close$5.91
Day High$7.11
Day Low$6.05
52W High$11.25
52W Low$3.43
Volume—
Avg Volume1.84M
Market Cap519.33M
P/E Ratio—
EPS$-2.51
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+127.0% upside
Current
$6.19
$6.19
Target
$14.05
$14.05
$11.84
$14.05 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 37.42M | 14.27M | 326.86M |
| Net Income | -253,567,161 | -167,775,411 | 9.66M |
| Profit Margin | -677.6% | -1,241.1% | 3.0% |
| EBITDA | -208,152,773 | -176,249,033 | 19.14M |
| Free Cash Flow | — | — | 10.52M |
| Rev Growth | +128.2% | +69.6% | +8.0% |
| Debt/Equity | 1.51 | 0.51 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |